Pfizer and BioNTech launch trial of Omicron-targeted COVID vaccine
Go back to Pfizer and BioNTech launch trial of Omicron-targeted COVID vaccine| (NASDAQ: BNTX) | Delayed: 91.60 -1.49 (1.6%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $93.09 | 52 Week High | $ | |||
| Open | $93.22 | 52 Week Low | $ | |||
| Day High | $93.76 | P/E | N/A | |||
| Day Low | $91.23 | EPS | $ | |||
| Volume | 443,532 | |||||
| Pfizer Inc. (NYSE: PFE) | Delayed: 26.87 +0.08 (0.30%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $26.79 | 52 Week High | $37.39 | |||
| Open | $26.76 | 52 Week Low | $28.25 | |||
| Day High | $27.02 | P/E | 16.28 | |||
| Day Low | $26.55 | EPS | $1.65 | |||
| Volume | 29,258,037 | |||||
